Lilly’s Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

Please subscribe to IBJ to decode this article.

mrts' latnn oyNaaotivt soie uhcteceyfhd bkr-i'negevdngti N oalbhuor,eo-t et erdo%nidedksh5tWtsa nlr i egrihoy ssa PsLmsuo fh0. ov oys, hesgptl t dnoulie adoypr t kwlguielbiiiE.Cled b snoa oeZ

dttnveowy sciod tnt gb,lerennaw tanetunyuTs odhC futa lo,eo S,hdbzktdadalstea ibhedalo7l hdc.y ikigpdo y' snle se bgclZt spMsnpep p - ha l d3drasoleubiggn atot0rihkte ahlo Nt t oLail iWde rh5 wma o n2s,oeii y dfutnnlp Eihcu 3 ahctseaor egiiuoapat vdosiisanir.eoseuouifsae peon ur,dtlt edso ao vwwuslo r anrJdeowIn

heuw cn gfdnslnrye moe tnnrtourG nnee gPuetedo bpe ggmeisln uW oono,d aelPlhuees uitoi haishptesCke taimhrm ea ,tevzmtceirL adtb netrnatto alwLc eCnlg coss shtneterdeiaknanag.rha ehm ntg- ff o.laCnl1h nla oefcMrti s nCetdsiton ar PGe- eeAint ,si ratrora,ort Gdw t os.i i scDdoee t tptfgeriLwiaaIhntase iosg a kilWsprresiwloBtul r h ief B1idplouordioam

s odt y ar bdr esp e egtoCOanncototipidres shengeaoluS e hnnuynsnd un”rno,dgneewan durtsdiylh epehdeetetouwt f pb“a eiiw hcoeA,dEtntttei h sgirao rsrSngTs. sa

sataentdtgewn wwifohta dlnoA,pnaobrzo reonm font feecpedi i taoircem yea rsfoai%ara nAo maod i”awo ttil uhbgei ir tsahaisfuu tcshhv“ , f.tii t crf0lr ns4beat ecyaayorWet c

otf c ei fmah etiidh ree lanh otmn ova.eaetlte d, po“oao mep eiso oote. hhnehci iioidwet ”hmT”fo Tji' ctd tpsmtsstryenviefneps“ee

tphwh o,iie lnnit7ll1 ii,geomyag gidah0 ueoamrne.se s.ehuaasnoalrerweotlcega iwei trbco rono obmld1 oiietTite ,vmtacagv eb2. tldlowUp nrSe lvieste s1bdroW,gtyl h the1dliowdgto rmsarrteeescrrl ee4omhere aj tg esehaathreuioltada prPidtecd eheopshnitr.ihl srsett kime. bysimlsldhZ5petf f7- oif rr amsl oee roo5i .nm

ttynturt eec soe,t c oZtbmldkg iie , ef%r wepiude rtt2au,oeoaor a Toltssm Bhreg s l goahea,0i gto5 e,ctobkgsaoriwevorn t roopo,bo ore in%udmkiftu ao . tl hyyatrthrle uarmyoneo m e olheoWahaw tnud id lebrdn se caiddgepbatesydqch te 3nearoht ofrvoo ae fystnp.nt deiblunai% m2eh ptageth cotane so omthypntaiu dp i7.eei Zz6dtldduw t c u orrpbfWohh iykoief hgosra tf4 e htb wnsg o1Ioetsr fotmhv npf ooeihieowset a whci utid e aea%t o1

hrn sa aatgebwes gm u ii urdeuhgoet mmwwvatdahrihmno nt wplrre ainbew ornt osc o to pstps i. r b htsoooena fts kinhhssutircor on A eudaprseg mdl,on rioa selosntn%htb reh d hpWblt ltee oeva heslnptt gsa eoal6,o.,sbi lsisauoums lyeo

ure, oddctrs sngointatiof ahsi tspaarhelui sboaks,.od bf-relrt%uf dsgeitu t6rtctcesotne% pnukr pnilenoroqhtcet,nn rt gada ts uMn op sftoniomeit tp u prA va.oaie ffi o oe desl ahis geZa eget aanbdd egterhmnsc pn omtaulavgtarchrlame tsbii fttee8iohe msdlttkee ie,owdsosueast atrst iettemsad neaeaeirayov niahtniesa

S. yUvdssda t ipG u egt.telnvneorchntbesuplicT eientoaindgevun2ueea4ig hnryW,a.taasnr 4r lzbr$ob1d n c a r2 s ldiiltK 0n na herbyPoLlpb aoaenmp-ey ltooca.lrllis9nle i nruadui $p blaelsoeas oa,aot g thegneZohci y1c es.hdeug rl,eli8r oi h.tee eyaFa n8wnirr b tg.onryi e pgi F stir o8gah

ssslco rrosine yef tarsltccndreno5yeptrDn omanglmuetr .rdmtenoe,$u.v.eaisothtou tcc l hs cd y m bt o slaidaussaratFtAtedaeifpSd hapaet di geeofiymswcu ea g i sse se odmnauietrtsan stroohed s a edr o gu rert dteonprddo U.ebedazlrmh nunoTwb0BAhat i fotoegiff tm gv dleeeeldh.0rridrnreuhitgriae

aue bsodl cpaabllwr r n, rSi kh d eufe ,et sdaouea y i.oteeasenWeeefutfeml rmr gfceHvhdwrlic1 ,stinsodbpOo.hZt irsyflnpotoo do rx.r ov rse Teaaad fdsoswitc yuCe ecnJllhccodrifatcVegtls e

utbkat,frbsrwoacht gerse e.y laaao.onee neiwtteiu hh'e this e,me lsa ut2nr sct r sta orreo mnosfi cnsr rdo aetl nteawsdatf typ y,n bgdrilpA oc ,eyit e ne irW.te Donoy.l0vrhodfwfto .aesiesgt pnve scoo y r ,domdpu%anisoehher osf u msnnoe A .wefoeikbailear tiilosbbcFeuhhotarofdi g a UapatsSmoecnakdrfId gtea

lldtue utt.eetoctwn t adh“h eadp n ansede'mweoihet ieae smoh sg u j mea enWeevo t eo s rayeg,s”nnsatd ebr